The IMS Commence for Healthcare Informatics has produced a report on the most widely-used prescription drugs in the US in 2010. The Initiate, an initiative of IMS Wellbeing, was established early in This year’s to strengthen global healthcare relationship and “to work in tandem by using government agencies, academic institutions, the life sciences business and payers to drive a research plan dedicated to addressing today’s health-related challenges”.
The IMS report underlines the continuation of a major trend on the way to generic drugs over brandnames, with 78 percent with the year’s 4 billion prescription medications written for generic medicines. Not surprisingly, the widely prescribed by doctors generic drugs are not the particular drugs generating the most money for your pharmaceutical companies. The top revenue makers are brand name drugs of which generic versions are not yet available. The survey noted that generic drug substitution for brand name medication whose patents expired cost prescription drug companies $12.5 billion truly.
Topping the list of the country’s most widely used prescription drugs with 131.Two prescriptions is the opioid analgesic hydrocodone in addition to acetaminophen. Second on the list is simple Zocar (simvastin), with over 94 million prescription medications.
Other prescription drugs in the top ten include brand name and commonly used isinopril (a blood pressure drug), a thyroid problem hormone generic Synthroid, the angina/blood tension drug generic Norvasc, the antacid common Prilosec, the antibiotics azithromycin and amoxicillin, your diabetes medication generic glucophage (Metformin), as well as other brand names of the water pill hydrochlorothiazide.
Americans spent $307 billion upon prescription drugs in 2010, with the top sellers being the statin Lipitor ($7.Only two billion), the antacid drug Nexium ($6.3 billion), the blood thinner Plavix ($6.1 billion), the allergies inhaler Advair Diskus ($4.7 billion), the antipsychotics Abilify ($4.Some billion) and Seroquel ($4.4 billion), the oral asthma medicine Singulair ($4.1 billion), the bad cholesterol drug Crestor ($3.8 billion), the actual diabetes drug Actos ($3.5 billion dollars), and the anemia drug Epogen ($3.3 thousand).
The pharmaceutical industry should expect to take another major reach soon when the diabetes substance Lantus, a , becomes available in common form in several countries, which includes India. Generic Lantus will then turn into available through an online Canadian pharmacy with a valid prescription. Online Canadian pharmacies can often offer simple prescription drugs before they are available in us states, due to less restrictive eclatant laws.
